Copenhagen-based Monsenso has teamed-up with reinsurance company Gen Re to help insurance companies take advantage of Monsenso's mHealth solution, which can assist in the prevention, early intervention and treatment of mental illness.
Specifically, Monsenso's solution provides practical care to people with behavioural disorders, and has the potential to improve the prevention and management of disability claims. It enables individuals to self-monitor their lifestyle and their symptoms, helping them recover faster from mental illness.
The two companies will work together to help insurance companies offer an enhanced service to their customers, and reduce costs along the way by helping customers return to work more quickly, and avoid becoming ill again.
"The objective of this partnership is to promote the use of mHealth technology among insurance companies," Thomas Lethenborg, CEO at Monsenso, said in a statement. "With this technology, their customers can get better faster by receiving better mental health care, while reducing costs at the same time."
With its origins in the University of Copenhagen, the Monsenso mHealth solution for mental illnesses holds a CE Mark and a TGA certification. It is currently being used in a clinical capacity in the UK, Denmark, Norway, Sweden, Germany and Australia to support the treatment of a wide range of mental and behavioural disorders.
Gen Re delivers reinsurance solutions to the Life/Health and Property/Casualty insurance industries. With $14 billion in capital and approximately $6 billion in premiums, it is one of the leading reinsurers in the world with a global network of offices in key reinsurance markets.